ConductScience.org, home

Paper28782884

Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.

Hallek M. Am J Hematol, 2017. Cited by 193 papers, by iCite.

Cite this record

ConductScience Library. Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment. Papers, record 28782884. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/28782884

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Chronic lymphocytic leukemia: 2017 update on diagnosis, risk stratification, and treatment.
PubMed
Journal
Am J Hematol
PubMed
Year
2017
PubMed
Publication types
Journal Article, Review
PubMed
Citations, by iCite
193
iCite
Relative citation ratio, by iCite
7.12
iCite
Revised in PubMed
2022-04-10
PubMed

Authors1

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Hallek MMichael

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Antineoplastic Combined Chemotherapy ProtocolsMajor topic
Chromosome DeletionMajor topic
Leukemia, Lymphocytic, Chronic, B-CellMajor topic
Smith-Magenis SyndromeMajor topic
Tumor Suppressor Protein p53Major topic
Adenine
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Chromosomes, Human, Pair 17
Humans
Piperidines
Pyrazoles
Pyrimidines
Risk Assessment
Rituximab

Source PubMed

Download CSV of topics

Cited by135

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 193 citations.

PMIDTitleJournalYearIn PapersSource
42458174Safety and Management of Targeted Therapies for Relapsed/Refractory Chronic Lymphocytic Leukemia.Drug Saf2026https://conductscience.org/library/papers/42458174PubMed
42450116Complex TP53 Alterations with del(17p) and del(13q) in Chronic Lymphocytic Leukemia: Clinical Implications from a Case-Based Review.Int J Mol Sci2026https://conductscience.org/library/papers/42450116PubMed
42001129Concurrent hepatic cirrhosis and chronic lymphocytic leukemia: a challenging coexistence: a case report.J Med Case Rep2026https://conductscience.org/library/papers/42001129PubMed
41673825Pretreatment immunoglobulin profiles and survival outcomes in hematologic malignancies and autoimmune cytopenias: a comparative cohort analysis.BMC Immunol2026https://conductscience.org/library/papers/41673825PubMed
41181769Comparison of One-Year Adverse Events Between First- and Second-Generation Bruton's Tyrosine Kinase Inhibitors: A Retrospective Study.Cureus2025https://conductscience.org/library/papers/41181769PubMed
40996474Chronic lymphocytic leukemia: criteria for first-line therapeutic choice-an opinion paper.Med Oncol2025https://conductscience.org/library/papers/40996474PubMed
40886283Circular RNAs and Cancers.Adv Exp Med Biol2025https://conductscience.org/library/papers/40886283PubMed
40569983Global, regional, and national burden of leukemia: Epidemiological trends analysis from 1990 to 2021.PLoS One2025https://conductscience.org/library/papers/40569983PubMed
39606680Overview on Immunopathology of Chronic Lymphocytic Leukemia and Tumor-Associated Antigens with Therapeutic Applications.Avicenna J Med Biotechnol2024https://conductscience.org/library/papers/39606680PubMed
39417189Molecular significance of circRNAs in malignant lymphoproliferative disorders: pathogenesis and novel biomarkers or therapeutic targets.Am J Cancer Res2024https://conductscience.org/library/papers/39417189PubMed
39202022Integrative Analysis of Multi-Omics Data to Identify Deregulated Molecular Pathways and Druggable Targets in Chronic Lymphocytic Leukemia.J Pers Med2024https://conductscience.org/library/papers/39202022PubMed
38920669
Lysosome-Disrupting Agents in Combination with Venetoclax Increase Apoptotic Response in Primary Chronic Lymphocytic Leukemia (CLL) Cells Mediated by Lysosomal Cathepsin D Release and Inhibition of Autophagy.
Cells2024https://conductscience.org/library/papers/38920669PubMed
38469292An unappreciated cell survival-independent role for BAFF initiating chronic lymphocytic leukemia.Front Immunol2024https://conductscience.org/library/papers/38469292PubMed
38443660Final results on effectiveness and safety of Ibrutinib in patients with chronic lymphocytic leukemia from the non-interventional FIRE study.Ann Hematol2025https://conductscience.org/library/papers/38443660PubMed
38426852The global burden of childhood and adolescent leukaemia and attributable risk factors: An analysis of the Global Burden of Disease Study 2019.J Glob Health2024https://conductscience.org/library/papers/38426852PubMed
38348963Real-world analysis of adverse event rates after initiation of ibrutinib among Medicare beneficiaries with chronic lymphocytic leukemia.Cancer Med2024https://conductscience.org/library/papers/38348963PubMed
38174814Maintenance therapy for chronic lymphocytic leukaemia.Cochrane Database Syst Rev2024https://conductscience.org/library/papers/38174814PubMed
37900812Delayed Diagnosis of T-Cell Prolymphocytic Leukemia: Approach to Chronic Lymphocytosis.Case Rep Oncol2023https://conductscience.org/library/papers/37900812PubMed
37770269
Protocol for a multicentre randomised controlled trial examining the effects of temporarily pausing Bruton tyrosine kinase inhibitor therapy to coincide with SARS-CoV-2 vaccination and its impact on immune responses in patients with chronic lymphocytic leukaemia.
BMJ Open2023https://conductscience.org/library/papers/37770269PubMed
37426051Determinants of Time-to-Death of Chronic Lymphocytic Leukemia Patients at Felege Hiwot Referral Hospital, Bahir Dar, Ethiopia.Cancer Inform2023https://conductscience.org/library/papers/37426051PubMed

See all 135 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CD5921PubTator's text mininghttps://conductscience.org/library/genes/921NCBI Gene
KRT2054474PubTator's text mininghttps://conductscience.org/library/genes/54474NCBI Gene
TP537157PubTator's text mininghttps://conductscience.org/library/genes/7157NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • References
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/28782884

GET https://conductscience.org/api/papers/v1/28782884/cited_by?page=2